To the best of our knowledge, this is the first (research) randomized clinical trial that assesses how patient respond to the nonsurgical periodontal treatment based on their blood group phenotype.
The aim of this study is to find out if one blood group phenotype is more responsive than the others to the nonsurgical periodontal treatment.